IDEALIFT™ fights against skin sagging and improves resistance to gravity. It is composed of a lipopeptide which sequence is based on a dipeptide naturally present in the body. OVALISS™ is based on a natural substance (Glaucine) that erases the double chin and visibly reshapes the facial contours by stimulating lipolysis and inhibiting formation of new adipocytes thanks to a regulation of the calcium flow.
Sederma, a member of the Croda International Group, is dedicated to the development of active ingredients for the Personal Care and Cosmetic. Sederma specializes in a wide range of cosmetic ingredients for skin and hair care products, including a unique range of biochemical actives with substantiated efficacy for sebum regulation, protection from free radicals, skin firming, and wrinkle reduction.
UL hat diese Informationen vom Hersteller des Produktes übernommen. UL unternimmt umfangreiche Maßnahmen, um die Richtigkeit dieser Informationen sicherzustellen. Dennoch übernimmt UL keinerlei Verantwortung für diese Angaben und rät, nach der Materialauswahl die Angaben mit dem Hersteller direkt zu verifizieren.
Sederma (part of Croda, Inc) stellt seine Produktinformationen in den unten aufgezeigten Regionen zur Verfügung:
Lists combine the ease of Bookmarks with the versatility of Tags. Instead of one collection of bookmarked items, create as many collections, called "Lists," as you need.
Find the link to your List page in the user menu.
All Tags have been converted to separate Lists, and your bookmarked items have been saved to a "Bookmarks" List.
When you click the Add to List button, a dropdown of your existing Lists appears. Click the List name to which you want to add this product or formula.
You can also create a new List. Simply click "Create a New List" and enter a name.
When you define a new List, the current item is automatically added to it. You can add a product or formula to as many Lists as you need.
Easily see which Lists this item appears in, and quickly go to that List from the links that appear on the page.
